-  - Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
-EUR - -
Turnover: -
-Bid Size: - -Ask Size: - 1.21 bill.EUR - -

Business description

DocMorris AG is one of Europe's leading online pharmacy and one of Switzerland's foremost wholesale suppliers to medical practitioners. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management in order to increase therapy safety. The creation of added value and a pronounced patient orientation company as an important strategic partner for service providers, cost units and industry.
 

Management board & Supervisory board

CEO
Walter Hess
Management board
Daniel Wüest, Madhu Nutakki, Kaspar Niklaus, David Masó
Supervisory board
Walter Oberhänsli, Prof. Stefan Feuerstein, Prof. Dr. Andréa Belliger, Rongrong Hu, Dr. Christian Mielsch, Florian Seubert
 

Company data

Name: DocMorris AG
Address: Walzmühlestrasse 49,CH-8500 Frauenfeld
Phone: -
Fax: -
E-mail: -
Internet: https://corporate.docmorris.com/de/
Industry: Consumer Goods
Sector: Retailers
Sub sector: -
End of financial year: 12-31
Free Float: -
IPO date: 2017-07-06

Investor relations

Name: Dr. Daniel Grigat
IR phone: +41 52 560 58 10
IR Fax: -
IR e-mail: ir@docmorris.com

Company calendar

CW 11 | 2025-03-13 Annual Report
CW 16 | 2025-04-17 Interim Report 1st Quarter/3 Months
CW 19 | 2025-05-08 General Shareholder Meeting
CW 34 | 2025-08-19 Interim Report 2nd Quarter/6 Months
CW 42 | 2025-10-16 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
85.37%
Frank M. Sands
 
4.93%
Patrick Schmitz-Morkramer Patrick Bierbaum
 
3.79%
Benjamin Leslie Levine
 
3.02%
BlackRock, Inc
 
2.89%